• 1
    Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA 2010; 303:235241.
  • 2
    Jain S, Kamimoto L, Bramley AM et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med 2009; 361:19351944.
  • 3
    Louie JK, Acosta M, Winter K et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302:18961902.
  • 4
    Gill JR, Sheng ZM, Ely SF, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010; 134:235243.
  • 5
    Morgan OW, Bramley A, Fowlkes A et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS ONE 2010; 5:e9694.
  • 6
    Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009; 14 pii:19309.
  • 7
    Fiore AE, Shay DK, Broder K et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58:152.
  • 8
    Kelly HA, Grant KA, Williams S, Fielding J, Smith D. Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection. Med J Aust 2009; 191:146149.
  • 9
    Smith AG, Sheridan PA, Tseng RJ, Sheridan JF, Beck MA. Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology 2009; 126:268279.
  • 10
    Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J Immunol 2010; 184:31273133.
  • 11
    Marti A, Marcos A, Martinez JA. Obesity and immune function relationships. Obes Rev 2001; 2:131140.
  • 12
    Smith AG, Sheridan PA, Harp JB, Beck MA. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 2007; 137:12361243.
  • 13
    Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med 1986; 314:1393.
  • 14
    Buchweitz JP, Harkema JR, Kaminski NE. Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol Pathol 2007; 35:424435.
  • 15
    Procaccini C, Lourenco EV, Matarese G, La Cava A. Leptin signaling: a key pathway in immune responses. Curr Signal Transduct Ther 2009; 4:2230.
  • 16
    Collins S, Martin TL, Surwit RS, Robidoux J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 2004; 81:243248.
  • 17
    Petro AE, Cotter J, Cooper DA, Peters JC, Surwit SJ, Surwit RS. Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism 2004; 53:454457.
  • 18
    Rossmeisl M, Rim JS, Koza RA, Kozak LP. Variation in type 2 diabetes – related traits in mouse strains susceptible to diet-induced obesity. Diabetes 2003; 52:19581966.
  • 19
    Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988; 37:11631167.
  • 20
    Qi L, Kash JC, Dugan VG et al. Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J Virol 2009; 83:37543761.
  • 21
    Memoli MJ, Tumpey TM, Jagger BW et al. An early ‘classical’ swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. Virology 2009; 393:338345.
  • 22
    Cavigelli SA, Monfort SL, Whitney TK, Mechref YS, Novotny M, McClintock MK. Frequent serial fecal corticoid measures from rats reflect circadian and ovarian corticosterone rhythms. J Endocrinol 2005; 184:153163.
  • 23
    Ueno N, Asakawa A, Inui A. Blunted metabolic response to fasting in obese mice. Endocrine 2007; 32:192196.
  • 24
    Saad F, Gooren LJ. The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2. J Obes 2011; pii:471584.
  • 25
    Kalter SS, Smolin HJ, McElhaney JM, Tepperman J. Endocrines and their relation to influenza virus infection. J Exp Med 1951; 93:529538.
  • 26
    Kalter SS, Stuart DC, Tepperman J. Alterations in rate of influenza virus proliferation produced by growth hormone and testosterone. Proc Soc Exp Biol Med 1950; 74:605607.
  • 27
    Klein SL, Passaretti C, Anker M, Olukoya P, Pekosz A. The impact of sex, gender and pregnancy on 2009 H1N1 disease. Biol Sex Differ 2010; 1:5.
  • 28
    Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH. Cortisol metabolism in human obesity: impaired cortisone[RIGHTWARDS ARROW]cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 1999; 84:10221027.
  • 29
    Liu Y, Nakagawa Y, Wang Y et al. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice. J Mol Endocrinol 2008; 41:5364.
  • 30
    Morens DM, Taubenberger JK, Fauci AS. The 2009 H1N1 pandemic influenza virus: what next? MBio 2010; 1:e0021110.